ST3GAL1 and βII-spectrin pathways control CAR T cell migration to target tumors.

Autor: Hong Y; Department of Microbiology and Immunology, David H. Smith Center for Vaccine Biology and Immunology, University of Rochester, Rochester, NY, USA., Walling BL; Department of Microbiology and Immunology, David H. Smith Center for Vaccine Biology and Immunology, University of Rochester, Rochester, NY, USA., Kim HR; Department of Microbiology and Immunology, David H. Smith Center for Vaccine Biology and Immunology, University of Rochester, Rochester, NY, USA., Serratelli WS; Department of Microbiology and Immunology, David H. Smith Center for Vaccine Biology and Immunology, University of Rochester, Rochester, NY, USA., Lozada JR; Department of Microbiology and Immunology, David H. Smith Center for Vaccine Biology and Immunology, University of Rochester, Rochester, NY, USA., Sailer CJ; Department of Microbiology and Immunology, David H. Smith Center for Vaccine Biology and Immunology, University of Rochester, Rochester, NY, USA.; Department of Pathology, University of Rochester Medical Center, Rochester, NY, USA., Amitrano AM; Department of Microbiology and Immunology, David H. Smith Center for Vaccine Biology and Immunology, University of Rochester, Rochester, NY, USA.; Department of Pathology, University of Rochester Medical Center, Rochester, NY, USA., Lim K; Department of Microbiology and Immunology, David H. Smith Center for Vaccine Biology and Immunology, University of Rochester, Rochester, NY, USA., Mongre RK; Department of Microbiology and Immunology, David H. Smith Center for Vaccine Biology and Immunology, University of Rochester, Rochester, NY, USA., Kim KD; Department of Convergent Research of Emerging Virus Infection, Korea Research Institute of Chemical Technology, Daejeon, Korea., Capece T; Department of Microbiology and Immunology, David H. Smith Center for Vaccine Biology and Immunology, University of Rochester, Rochester, NY, USA., Lomakina EB; Department of Biomedical Engineering, University of Rochester Medical Center, Rochester, NY, USA., Reilly NS; Department of Physics and Astronomy, University of Rochester, Rochester, NY, USA., Vo K; Department of Microbiology and Immunology, David H. Smith Center for Vaccine Biology and Immunology, University of Rochester, Rochester, NY, USA., Gerber SA; Department of Surgery, University of Rochester, Rochester, NY, USA., Fan TC; Institute of Stem Cell and Translational Cancer Research, Chang Gung Memorial Hospital at Linkou and Chang Gung University, Taoyuan, Taiwan., Yu AL; Department of Pediatrics/Hematology Oncology, University of California in San Diego, San Diego, CA, USA., Oakes PW; Department of Physics and Astronomy, University of Rochester, Rochester, NY, USA., Waugh RE; Department of Biomedical Engineering, University of Rochester Medical Center, Rochester, NY, USA., Jun CD; School of Life Sciences, Gwangju Institute of Science and Technology (GIST), Gwangju, Korea., Reagan PM; Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY, USA., Kim M; Department of Microbiology and Immunology, David H. Smith Center for Vaccine Biology and Immunology, University of Rochester, Rochester, NY, USA. minsoo_kim@urmc.rochester.edu.

Publikováno v: Nature immunology [Nat Immunol] 2023 Jun; Vol. 24 (6), pp. 1007-1019. Date of Electronic Publication: 2023 Apr 17.

Identifying the Novel Inhibitors Against the Mycolic Acid Biosynthesis Pathway Target "mtFabH" of Mycobacterium tuberculosis .

Autor: Kumar N; School of Computational and Integrative Sciences, Jawaharlal Nehru University, New Delhi, India., Srivastava R; School of Computational and Integrative Sciences, Jawaharlal Nehru University, New Delhi, India., Mongre RK; Molecular Cancer Biology Laboratory, Cellular Heterogeneity Research Center, Department of Biosystem, Sookmyung Women's University, Seoul, South Korea.; Department of Microbiology and Immunology, David H. Smith Center for Vaccine Biology and Immunology, University of Rochester Medical Center, Rochester, NY, United States., Mishra CB; Department of Pharmacology and Chemical Biology, Baylor College of Medicine, Houston, TX, United States., Kumar A; Indian Council of Medical Research-Computational Genomics Centre, All India Institute of Medical Research, New Delhi, India.; Amity Institute of Integrative Sciences and Health, Amity University, Gurugram, India., Khatoon R; Amity Institute of Biotechnology, Amity University, Gurugram, India., Banerjee A; Amity Institute of Biotechnology, Amity University, Gurugram, India., Ashraf-Uz-Zaman M; Department of Pharmacology and Chemical Biology, Baylor College of Medicine, Houston, TX, United States., Singh H; Indian Council of Medical Research-Computational Genomics Centre, All India Institute of Medical Research, New Delhi, India., Lynn AM; School of Computational and Integrative Sciences, Jawaharlal Nehru University, New Delhi, India., Lee MS; Molecular Cancer Biology Laboratory, Cellular Heterogeneity Research Center, Department of Biosystem, Sookmyung Women's University, Seoul, South Korea., Prakash A; Amity Institute of Integrative Sciences and Health, Amity University, Gurugram, India.

Publikováno v: Frontiers in microbiology [Front Microbiol] 2022 May 06; Vol. 13, pp. 818714. Date of Electronic Publication: 2022 May 06 (Print Publication: 2022).

Emerging Importance of Tyrosine Kinase Inhibitors against Cancer: Quo Vadis to Cure?

Autor: Mongre RK; Molecular Cancer Biology Laboratory, Cellular Heterogeneity Research Center, Department of Biosystem, Sookmyung Women's University, Hyochangwon gil-52, Seoul 04310, Yongsan-gu, Korea.; Department of Microbiology & Immunology, David H. Smith CVBI, University of Rochester Medical Center, 601 Elmwood Avenue, Rochester, NY 14642, USA., Mishra CB; Department of Pharmacology & Chemical Biology, Baylor College of Medicine, Baylor Plaza, Houston, TX 77030, USA., Shukla AK; School of Biomedical Convergence Engineering, Pusan National University, Yangsan 50612, Gyeongsangnam-do, Korea., Prakash A; Amity Institute of Integrative Sciences and Health (AIISH), Amity University Haryana, Gurgaon 122413, India., Jung S; Molecular Cancer Biology Laboratory, Cellular Heterogeneity Research Center, Department of Biosystem, Sookmyung Women's University, Hyochangwon gil-52, Seoul 04310, Yongsan-gu, Korea., Ashraf-Uz-Zaman M; Department of Pharmacology & Chemical Biology, Baylor College of Medicine, Baylor Plaza, Houston, TX 77030, USA., Lee MS; Molecular Cancer Biology Laboratory, Cellular Heterogeneity Research Center, Department of Biosystem, Sookmyung Women's University, Hyochangwon gil-52, Seoul 04310, Yongsan-gu, Korea.

Publikováno v: International journal of molecular sciences [Int J Mol Sci] 2021 Oct 28; Vol. 22 (21). Date of Electronic Publication: 2021 Oct 28.

Identifying the natural polyphenol catechin as a multi-targeted agent against SARS-CoV-2 for the plausible therapy of COVID-19: an integrated computational approach.

Autor: Mishra CB; College of Pharmacy, Sookmyung Women's University, Seoul, South Korea., Pandey P; Department of Chemistry & Biochemistry, University of Oklahoma, OK, USA., Sharma RD; Amity Institute of Technology, Amity University, Haryana., Malik MZ; School of Computational and Integrative Sciences, Jawaharlal Nehru University, New Delhi, India., Mongre RK; College of Pharmacy, Sookmyung Women's University, Seoul, South Korea., Lynn AM; School of Computational and Integrative Sciences, Jawaharlal Nehru University, New Delhi 110067, India., Prasad R; Amity Institute of Biotechnology and is the dean of Faculty of Science Engineering and Technology, Amity University Haryana, Haryana 122413, India., Jeon R; College of Pharmacy, Sookmyung Women's University, Seoul, South Korea., Prakash A; Amity Institute of Integrative Sciences and Health, Amity Institute of Integrative Sciences and Health, Amity University, Haryana.

Publikováno v: Briefings in bioinformatics [Brief Bioinform] 2021 Mar 22; Vol. 22 (2), pp. 1346-1360.

Exploring the Role of TRIP-Brs in Human Breast Cancer: An Investigation of Expression, Clinicopathological Significance, and Prognosis.

Autor: Mongre RK; Molecular Cancer Biology Laboratory, Cellular Heterogeneity Research Center, Department of Biosystem, Sookmyung Women's University, Hyochangwon gil-52, Yongsan-Gu, Seoul 140-742, Republic of Korea., Mishra CB; College of Pharmacy, Sookmyung Women's University, Hyochangwon gil-52, Yongsan-Gu, Seoul 140-742, Republic of Korea., Jung S; Molecular Cancer Biology Laboratory, Cellular Heterogeneity Research Center, Department of Biosystem, Sookmyung Women's University, Hyochangwon gil-52, Yongsan-Gu, Seoul 140-742, Republic of Korea., Lee BS; Molecular Cancer Biology Laboratory, Cellular Heterogeneity Research Center, Department of Biosystem, Sookmyung Women's University, Hyochangwon gil-52, Yongsan-Gu, Seoul 140-742, Republic of Korea., Quynh NTN; Molecular Cancer Biology Laboratory, Cellular Heterogeneity Research Center, Department of Biosystem, Sookmyung Women's University, Hyochangwon gil-52, Yongsan-Gu, Seoul 140-742, Republic of Korea., Anh NH; Molecular Cancer Biology Laboratory, Cellular Heterogeneity Research Center, Department of Biosystem, Sookmyung Women's University, Hyochangwon gil-52, Yongsan-Gu, Seoul 140-742, Republic of Korea., Myagmarjav D; Molecular Cancer Biology Laboratory, Cellular Heterogeneity Research Center, Department of Biosystem, Sookmyung Women's University, Hyochangwon gil-52, Yongsan-Gu, Seoul 140-742, Republic of Korea., Jo T; Molecular Cancer Biology Laboratory, Cellular Heterogeneity Research Center, Department of Biosystem, Sookmyung Women's University, Hyochangwon gil-52, Yongsan-Gu, Seoul 140-742, Republic of Korea., Lee MS; Molecular Cancer Biology Laboratory, Cellular Heterogeneity Research Center, Department of Biosystem, Sookmyung Women's University, Hyochangwon gil-52, Yongsan-Gu, Seoul 140-742, Republic of Korea.

Publikováno v: Molecular therapy oncolytics [Mol Ther Oncolytics] 2020 Sep 16; Vol. 19, pp. 105-126. Date of Electronic Publication: 2020 Sep 16 (Print Publication: 2020).